SAP SE (NYSE: SAP) announced plans to collaborate with Accenture, Capgemini and Deloitte to accelerate customer adoption of SAP S/4HANA® Cloud in the process manufacturing, discrete manufacturing...

From May 26th to May 29th, the China International Big Data Industry Expo 2018 was launched in Guiyang (http://www.bigdata-expo.org/?lang=en). This year, the expo was jointly hosted by the...

Ningbo, a coastal city in East China's Zhejiang province which has the busiest port in the world by cargo tonnage, is set to host the 4th China-CEEC Investment and Trade Expo (China-CEEC Expo)...

Eisai Inc. and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from presentations of new data and analyses of LENVIMA® (lenvatinib), an orally...

Salix Pharmaceuticals, a leading specialty pharmaceutical company committed to the prevention and treatment of gastrointestinal disorders, today announced the presentation of new investigational...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that its investigational treatment solriamfetol demonstrated long-term maintenance of efficacy and a tolerable safety profile in the...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Xyrem® (sodium oxybate) oral solution, CIII, demonstrated long-term efficacy for up to one year in reducing cataplexy and excessive...

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced positive data from the Phase 2 CAPTIVATE (PCYC-1142) study evaluating IMBRUVICA® (ibrutinib) in combination...

Polaris Group announced results from a phase 1 clinical study, showing that Polaris lead therapeutic candidate ADI-PEG 20 in combination with FOLFOX demonstrated promising efficacy for heavily...

Salix Pharmaceuticals, Ltd. ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, will present Phase...